Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
March 01 2021 - 8:05AM
Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced it will
report financial results for the fourth quarter and full year 2020
after market close on Monday, March 29, 2021. Company management
will be webcasting a conference call beginning at 1:30 p.m. Pacific
Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the Investor section of Seer’s website at investor.seer.bio. An
archived replay will be available on the company’s website
following the event.
About SeerSeer™ is a life sciences company
focused on enabling exceptional scientific outcomes by
commercializing transformative products that will drive
breakthrough ideas by unlocking the deep, unbiased biological
information that can make them a reality. Seer is developing its
Proteograph™ Product Suite, which is an integrated solution
consisting of consumables, automation instrumentation and
proprietary software that performs deep, unbiased proteomics
analysis at scale in a matter of hours. Seer designed the
Proteograph to be efficient and easy-to-use, leveraging widely
adopted laboratory instrumentation to provide a decentralized
solution broadly available to life sciences researchers. Seer’s
Proteograph Product Suite is for research use only and is not
intended for diagnostic procedures. For more information, please
visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren
Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024